Hedge Fund - Mangrove Partners
Teva Pharmaceutical Industries Ltd (TEVA)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $67,380,830 | 5.49% | 2,158,950 | $24.64 |
| 2 | 2025 - Q3 (2025-09-30) | $47,232,387 | 3.49% | 2,338,237 | $17.56 |
| 3 | 2025 - Q2 (2025-06-30) | $32,387,477 | 3.48% | 1,932,427 | $16.14 |
| 4 | 2025 - Q1 (2025-03-31) | $29,701,403 | 3.21% | 1,932,427 | $17.86 |
| 5 | 2024 - Q4 (2024-12-31) | $42,590,691 | 4.7% | 1,932,427 | $18.19 |
| 6 | 2024 - Q3 (2024-09-30) | $38,691,481 | 3.32% | 2,147,141 | $17.50 |
| 7 | 2024 - Q2 (2024-06-30) | $44,885,003 | 3.44% | 2,762,154 | $15.40 |
| 8 | 2024 - Q1 (2024-03-31) | $38,973,993 | 2.7% | 2,762,154 | $12.61 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center